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Abstract
Background: Primary ciliary dyskinesia (PCD) is a rare autosomal recessive disorder characterised by abnormal
ciliary motion and impaired mucociliary clearance, leading to recurrent respiratory infections, sinusitis, otitis media
and male infertility. Some patients also have laterality defects. We recently reported the identification of three
disease-causing PCD genes in the Irish Traveller population; RSPH4A, DYX1C1 and CCNO. We have since assessed an
additional Irish Traveller family with a complex phenotype involving PCD who did not have any of the previously
identified PCD mutations.
Case presentation: In this study we report on a family with three children with PCD and various laterality defects. In
addition, one child (V:1) has mild-to-moderate developmental delay and one child has speech delay (V:2). Developmental
delay is not usually associated with PCD and is likely to be caused by an additional genetic abnormality. Transmission
electron microscopy showed variable inner and outer dynein arm defects. Exome sequencing identified a homozygous
missense variant in CCDC103 (c.461A > C; p.His154Pro) as the most likely cause of the PCD and laterality defects in this
family. However, as mutation in CCDC103 would not account for the developmental delay, array comparative genomic
hybridisation was undertaken and identified a maternally inherited gain of ~1.6 Mb (chr17:34,611,352-36,248,918). Gains
at this locus are associated with 17q12 duplication syndrome which includes speech and language delay.
Conclusion: We report on a variable and complex phenotype caused by the co-inheritance of a single gene mutation in
CCDC103 and a microduplication at 17q12, both on chromosome 17. The co-existence of a single gene and chromosome
disorder is unusual but accounts for the spectrum of clinical features in this family. In addition, our study brings the
total number of PCD genes in the Irish Traveller population to four and we suspect additional PCD genes are yet to be
identified. Although, on a global scale, PCD is associated with extensive genetic heterogeneity, finding such a high
number of causative PCD genes within the relatively small Irish Traveller population was unexpected.
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Background
Primary ciliary dyskinesia (PCD) is a rare, genetically het-
erogeneous respiratory disorder primarily characterised by
chronic sinopulmonary infections. Approximately 50 % of
patients with PCD also have an organ laterality defect.
The disorder occurs due to a defect in ciliary structure
and/or function. To date, 29 PCD genes have been identi-
fied (accounting for ~60 % of cases), 20 of which can
cause PCD with a laterality defect [1].
We recently reported the identification of pathogenic
variants in three different disease genes causing PCD
in the Irish Traveller population; RSPH4A (c.166dup;
p.Arg56Profs*11), DYX1C1 (~3.5 kb deletion) and CCNO
(c.258_262dup; p.Gln88Argfs*8) [1]. Each family had a
different type of ultrastructural ciliary defect, depending
on which gene was mutated. All patients had normal situs.
However, the DYX1C1 deletion has been observed to
cause PCD with laterality defects in an Irish Traveller
family (personal communication, Dr. Jane S Lucas). The
identification of three PCD genes within a population
of ~30,000-40,000 people was surprising and suggests that
there may be a selective advantage towards variation in
ciliary genes.
We have since assessed another Irish Traveller family
who have three children with PCD and variable laterality
defects (Fig. 1a). One child has situs inversus (V:1), one
has situs inversus totalis (V:2) and one child (V:3) has
left atrial isomerism and an atrioventricular septal defect
(AVSD). Sanger sequence analysis excluded the three pre-
viously identified PCD mutations in the Irish Traveller
population, suggesting that the family harboured a novel
mutation. We proposed to identify the underlying genetic




Genomic DNA was extracted from peripheral blood
lymphocytes of the 3 affected children and unaffected
parents. The study protocol was approved by the ethics
committee of Temple Street Children’s University Hospital
(Dublin, Ireland).
Fig. 1 Irish Traveller family with PCD and laterality defects. a The family has three children with PCD and various laterality defects. Child V:3 was
born prematurely and died post-delivery. DNA was available from all family members. b Transmission electron microscopy of bronchial epithelium
samples from patient V:2 (1–4) and patient V:1 (5–8) showed a reduced number of dynein arms in some but not all cilia. The phenotype varied
from normal ultrastructure (7) through shortened dynein arms (5, arrow) to complete absence of dynein arms. c The CCDC103 NM_001258395.1:c.461A > C
was validated by Sanger sequence analysis. The inverted triangle indicates the position of the mutated A > C base on the forward strand which results
in the substitution of His (H) with Pro (P) at residue 154
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Patient V:1
Patient V:1 was well at birth (no neonatal respiratory
distress) but has a history of multi-trigger persistent
wheeze, recurrent respiratory tract and ear infections,
persistent nasal congestion and possible obstructive
sleep apnoea. He also had congenital cytomegalovirus
infection which may or may not be linked to moderate
bianural hearing loss. He had otitis media with effusion
on the left side and Eustachian tube dysfunction on the
right side. He has had grommets inserted twice and has
had his tonsils and adenoids removed. Sweat test and
immunoglobin profiles were normal. A diagnosis of PCD
with situs inversus was made. In addition, patient V:1
has mild-to-moderate developmental delay and a pectus
excavatum chest deformity. Cardiovascular exam was
normal. Chest x-ray was normal with no evidence of
dextrocardia. He had brain stem evoked responses which
were normal after grommet insertion. Despite normal
hearing, his speech is still limited to single words at age
5 years. His gross and fine motor skills are within nor-
mal limits. He has mild behavioural issues including
bruxism and hyperactivity.
Patient V:2
Patient V:2 is the only surviving child from a triplet
pregnancy. The other two triplets miscarried at 16 weeks
gestation. This child was well at birth (no respiratory
distress) but she presented with recurrent chest infec-
tions as a child and she currently has a wet productive
cough and rhinitis. She does not have sinusitis. She has
had grommets inserted for otitis media and is awaiting
removal of her tonsils and adenoids. Situs inversus tota-
lis was incidentally detected on chest X-ray. She has a
structurally normal heart. She has some speech delay.
Patient V:3
A fetal echocardiogram of patient V:3 showed that she
had left atrial isomerism. Antenatal scans did not iden-
tify any other internal malformations. She was born pre-
maturely at 26 + 3 weeks gestation following placental
abruption and weighed 1.48 kg at birth. Apgar scores
were one at 1 min and zero at 5 and 10 min. Full resus-
citation, including cardiopulmonary resuscitation, was
unsuccessful and she died. There was an antenatal diag-
nosis of a significant AVSD with hypoplastic right sided
tissue. This lesion would not have been treatable unless
the baby was born after 32 weeks gestation. She was also
dysmorphic with low set ears and broad spaced nipples.
Chromosome analysis showed a normal 46XX karyotype.
Post mortem was not performed.
Transmission electron microscopy
Nasal brushings from patients V:1 and V:2 were ana-
lysed at a PCD Diagnostic Service (University Hospital
Southampton NHS Foundation Trust) following a stan-
dard transmission electron microscopy (TEM) protocol [2].
Whole exome sequencing
DNA from two affected children (V:1 and V:2) was se-
lected for whole exome sequencing. The exonic DNA was
enriched with the SureSelect v5 Human All Exon Kit
(Agilent Technologies, Santa Clara), and sequenced on
an Illumina HiSeq 2500 (Aros Applied Biotechnology,
Denmark, now part of the Eurofins Genomics Organisation).
The 100 bp paired-end reads were aligned to the hg19 hu-
man reference genome. Quality control and variant and
indel identification were performed as previously described
[1]. Assuming an autosomal recessive model, we prioritised
variants that were (i) autosomal, (ii) absent or present with
a frequency <1 % in dbSNP130, NHLBI Exome Variant
Server database and 1000 Genomes, (iii) homozygous,
(iv) absent in our 60 Irish control exomes and (v) shared
by the affected siblings.
Array comparative genomic hybridisation (CGH)
Array CGH was performed using the Agilent design
028469 (~60,000 oligonucleotide probes), with a median
resolution of 120 kb. Genomic copy number variants were
analysed with Cytogenomics v2.7.22 software (Agilent).
Validation and segregation
Validation and segregation analysis of the CCDC103
NM_001258395.1 c.461A>C variant was undertaken by poly-
merase chain reaction and Sanger sequencing (Additional
file 1: Table S1).
Findings
TEM in patients V:1 and V:2 showed a high percentage
of outer and inner dynein arm defects (Fig. 1b). The pro-
portion of cilia with dynein arm defects was not within
the range usually seen in patients with PCD but consid-
erably higher than normal (Additional file 1: Table S2).
Further investigation was therefore recommended fol-
lowing this inconclusive result. Whole exome sequen-
cing was pursued.
Analysis of the exome data identified 4 rare homozygous
variants shared by both siblings, only one of which is in a
gene related to ciliary function; CCDC103 (Additional
file 1: Table S3 and S4). CCDC103 is an essential gene for
dynein arm assembly, cilia motility and determination of
left-right asymmetry. The CCDC103 c.461A > C p.His154-
Pro variant (rs145457535) identified in this family has pre-
viously been associated with PCD, varying degrees of situs
abnormalities (in some cases) and dextrocardia [3, 4].
Sanger sequencing confirmed that all three affected chil-
dren are homozygous for CCDC103 c.461A > C and the
parents are obligate carriers (Fig. 1c).
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Array CGH was performed on account of the develop-
mental and speech delay in patients V:1 and V:2 and iden-
tified a gain of ~1.6 Mb at chr17:34,611,352-36,248,918
(Fig. 2). Gains at this locus are associated with 17q12
duplication syndrome (#614526) which includes speech
and language delay. Analysis of parental DNA showed
that the micro-duplication was maternally inherited. The
mother (IV:2) has significant hearing loss due to mas-
toiditis secondary to chronic ear infection. In her early
history, she did not talk until 5 years of age. She was also
diagnosed with a goitre and hyperthyroidism as an adult.
Conclusion
The present study involves three siblings from an Irish
Traveller family with PCD, laterality defects, dextrocar-
dia (one child) and developmental delay (two children).
Analysis of ciliary ultrastructure and beat has only been
reported for four patients with CCDC103 mutations; two
previously reported and two in the current study (Table 1).
The patients reported in this study showed reduced
numbers of dynein arms on TEM in comparison to
healthy controls, but not as low as typically found in PCD.
Whole exome sequencing identified CCDC103 c.461A > C
p.His154Pro as the most likely cause of the PCD and lat-
erality phenotype in this family. This finding brings the
number of PCD genes in the relatively small Irish Traveller
population to four, highlighting locus heterogeneity even
in a small endogamous population. Given the rarity of
PCD (1:15,000-30,000), finding such a high number of
causative genes in a genetically homogenous endogamous
population was unexpected.
The CCDC103 p.His154Pro variant has previously been
associated with PCD and laterality defects in families from
three other populations; two Pakistani families, one
German family and one Italian family [3, 4]. We now re-
port the presence of this particular variant in the Irish
Traveller population. Identification of the same variant
across multiple populations supports the causative nature
of the p.His154Pro variant and suggests either a founder
mutation or a mutation hotspot. Given the absence of any
known shared ancestry between the three populations,
this observation is more likely due to a spontaneous muta-
tion hotspot at cDNA position 461.
Almost 50 % of PCD patients have situs inversus totalis,
while at least 12 % have incomplete situs inversus or het-
erotaxy [5]. A total of nine PCD patients from five families
(including current study) have been reported to be homo-
zygous for the CCDC103 p.His154Pro variant (Table 1).
Laterality status ranges from situs solitus (normal) to situs
inversus totalis. This variation in laterality may be due to a
combination of timing and the suggested hypomorphic
nature of the p.His154Pro variant. The timing of alter-
ations during the patterning process has a profound effect
on the final laterality phenotype [6]. It is possible that the
p.His154Pro variant may result in varying levels of protein
of reduced functionality; patients with the least amount
of functional protein during the earliest steps in the
establishment of left-right asymmetry may develop situs
Fig. 2 Array comparative genomic hybridisation. Array CGH was undertaken for patient V:1 on account of his developmental delay. a Image from
Cytogenomics v2.7.22 software (Agilent) showing a ~1.6 Mb gain on 17q12 (hg19; chr17:34,611,352-36,248,918). b Screenshot from UCSC hg19
showing the 17 genes (UCSC) located within the duplicated region
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Table 1 Clinical and histological characterisation of patients homozygous for CCDC103 p.His154Pro
Patient ODA IDA Motility PCD Laterality Other Origin Cons Ref
UCL-143 Complete Complete n.a. + Normal Pakistani yes 3
II1 loss loss -
OP-1194 n.a n.a n.a. + Dextrocardia Pakistani yes 3
II1 -
OP-32 Reduction of ODAs No defect reported Reduced cilia beat amplitude + SI totalis German no 3
II1 -
OP-32 n.a. n.a Loss of beat coordination,
and cilia paralysis
+ SI abdominalis German no 3
II2 + - Italian no 4
D’Andrea et al. II-2 n.a n.a n.a. + SI totalis AVSDPFO Italian no 4
D’Andrea et al. II-3 n.a n.a n.a. + SI totalis AVSDOS Irish Traveller yes c.s.
Casey et al. V:1 Reduction in ODAs Reduction in IDAs n.d. + SI - Irish Traveller yes c.s.
Casey et al. V:2 Reduction in ODAs Reduction in IDAs n.d. + SI totalis -
Casey et al. V:3 n.d. n.d. n.d. Left atrial isomerism AVSD Irish Traveller yes c.s.
Features that are present and absent are denoted by + and – respectively. Abbreviations: AVSD atrioventricular septal defect, Cons consanguinity, c.s. current study, IDA inner dynein arm defects, n.a not available, n.d.














inversus totalis, whereas those retaining greater amounts
of functional protein may develop situs inversus abdomi-
nalis or have normal situs. Panizzi and colleagues also ob-
served considerable phenotypic variation in a zebrafish
p.His154Pro model, suggesting the influence of modifier
genes [3].
Of the three affected siblings with the CCDC103
p.His154Pro variant reported in the current study, only
one child (V:3) (with left isomerism) has an AVSD. Two
of the six previously reported patients with the p.His154-
Pro variant also had an AVSD (Table 1). Congenital
heart defects are not uncommon in patients with lateral-
isation disorders as laterality disturbance can affect heart
development. AVSD associated with laterality defects oc-
curs in approximately 91.2 % of right isomerism com-
pared to 56.8 % of left isomerism cases [7]. Genes
causative of AVSD have demonstrated incomplete pene-
trance and variable expression which correlates with the
presence of AVSD in 3/9 CCDC103 p.His154Pro pa-
tients to date.
While the CCDC103 variant explains the PCD, lateral-
ity defects and AVSD in this family, it is unlikely to ac-
count for the developmental delay. Array CGH analysis
showed that in addition to the CCDC103 gene mutation,
at least two of the children have a maternally inherited
17q12 microduplication of approximately 1.6 Mb. This
17q12 microdupliation overlaps with duplications pre-
viously reported in other patients (Fig. 3a). There is one
known disease gene, HNF1B (TCF2), located within the
critical region (Fig. 3b). Deletion of HNF1B is associated
with renal cysts and maturity-onset diabetes type 5 while
there is one report of a HNF1B duplication causing vari-
ous renal abnormalities [8, 9]. As the 17q12 duplication
identified in the current study includes this gene, it is
possible that the patients may be at risk of developing
renal cysts later in life, though this is an ultrarare feature
of the duplication syndrome. Furthermore, 17q12 dupli-
cations are associated with a wide phenotypic spectrum,
even in patients with the exact same breakpoints which
complicates genotype-phenotype correlation [10].
Patients carrying a 17q12 duplication present with a
variable phenotype characterised by intellectual disability
or developmental delay of various degree. Additional fea-
tures may include behavioural problems, brain abnor-
malities, epilepsy, esophageal atresia, renal abnormalities,
atrial septal defects, sex reversal and ocular anomalies
[11–15]. A 17q12 microduplication has also been identi-
fied in patients with autism spectrum disorder [16]. The
patients in the present study presented with mild-to-
moderate developmental delay only. The mother (IV:2),
who is the carrier of the microduplication, did not talk
until age 5, consistent with previously reported features of
17q12 microduplcation. Array CGH was not performed
on DNA from the deceased child (V:3). However, it is
plausible to suggest that she too had the 17q12 microdu-
plication as she had facial dysmorphism and widely spaced
nipples, which have been reported in patients with 17q12
anomalies. Of note, there is one previous report of a child
with PCD, dextrocardia, AVSD, mild facial dysmorphism
and wide spaced nipples [17]. However, the molecular
basis of the child’s disorder was not reported.
In terms of genetic counselling, it is important to try
and establish which clinical features are attributable to
each of the CCDC103 mutation and the 17q12 microdu-
plication. It is clear that the PCD, recurrent infections
and laterality defects are a direct result of the CCDC103
mutation. Although it is not uncommon for PCD patients
to have associated speech and language delay due to
conductive hearing loss caused by recurrent chronic oti-
tis media and effusions [18], we do not think this is the
case in the reported family. Brain stem evoked responses
were normal after grommet insertion in patient V:1.
Despite normal hearing, his speech is still limited to sin-
gle words (no sentences) by age 5 years. Therefore, the
speech and language delay together with his behavioural
issues are most likely attributable to the 17q12 microdu-
plication. While his sister (V:2) has only mild speech
delay, this variability is frequently found in patients with
17q12 microduplications whereby development can
range from normal to severely delayed.
It is interesting to note that the CCDC103 variant and
the microduplication are both located on chromosome
17. We do not believe that one genetic alteration
“caused” the other but it suggests co-inheritance. The
mother (IV:2) carries both the 17q12 microduplication
and the CCDC103 variant. At least two of her children
have inherited both the microduplication and the
CCDC103 variant, indicating that these two alterations
are in cis. The father (IV:1) carries the CCDC103 variant
only. Therefore, any child in this family who inherits the
CCDC103 variant from their mother, will also inherit
the microduplication provided there is no recombination
(Fig. 4). This suggests that any future children in this
family who present with PCD and/or laterality should
also be tested for the microduplication which is likely to
be co-inherited. Given that the parents are first cousins
(mothers are sisters), the CCDC103 variant carried by
each parent (IV:1 and IV:2) is likely the same mutation
inherited from a common ancestor. The DNA surround-
ing the CCDC103 variant should therefore be the same
on both the mother’s and father’s chromosome 17. How-
ever, the fact that the father does not carry the microdu-
plication suggests that this copy number alteration arose
recently as a de novo evolutionary event in either the
carrier mother (IV:2) or in her mother (III:4) (who is the
maternal aunt of her husband). These observations
suggest that there are two CCDC103 “alleles” in the
Traveller population; one which contains only the
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CCDC103 variant and another which contains both
the CCDC103 variant and the 17q12 microduplication.
Hence, it is possible for some Traveller patients to have
isolated PCD/laterality due to the CCDC103 alteration
while others will be at risk of the microduplication syn-
drome depending on which “allele” they inherit.
In conclusion, we report a rare finding of patients with
both a single gene disorder (CCDC103) and a chromosome
Fig. 3 17q12 microduplications. a UCSC Genome Browser (hg19) view of previously reported 17q12 microduplications and one large 12.4 Mb
duplication. The chromosomal region 17q11.2-q12 is shown together with UCSC genes. The coloured bars show the location and extent of the
duplicated region of the patients described here (red), and of other cases reported in the literature (blue). b Zoomed in view of genes within the
microduplication reported in this study (red) and previously reported 17q12 microduplications (blue). Duplications range in size from 300 kb
to 2.4 Mb
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disorder (17q12 microduplication) giving rise to a com-
plex and variable phenotype. Together, the two genetic
alterations account for the spectrum of clinical features
observed in the family. Our findings highlight the
importance of considering the possibility of more than
one genetic mutation in patients with a complex phe-
notype, which cannot be explained by abnormalities in
one gene alone.
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